Nic Uloth
19.8K posts


Iranian dad fatally beaten for using Starlink during web blackout; karate champ executed over protest trib.al/gOOGWOE






U.S. Sanctions Tighten Grip on Iran-China Oil Trade state.gov/releases/offic…








China, India among countries active in foreign interference and spying in Canada, CSIS says theglobeandmail.com/politics/artic…







A convicted former Harvard scientist is now the architect of China’s push to "blur the distinction between electronics and the human brain." Charles Lieber, once the world’s top-ranked chemist and chair of Harvard’s chemistry department, has resurfaced as the founding director of i-BRAIN in Shenzhen. Just three years after his U.S. federal conviction for lying about ties to the Thousand Talents Program, Lieber is overseeing a state-funded institute bankrolled by a government that has declared brain-computer interfaces a "national priority." The resource gap between his new lab and Harvard is staggering: Unlimited Primate Access: Lieber now has access to 2,000 primate cages at the Brain Science Infrastructure Shenzhen—a resource far beyond what was available at Harvard, which closed its primate center in 2015. Cutting-Edge Hardware: His lab recently installed a $2 million deep ultraviolet lithography system from ASML to print the microscopic circuits essential for neural implants. Billion-Dollar Backing: i-BRAIN is part of a "manicured" science hub where parent institutions operate with five-year budgets totaling roughly $2 billion. While Lieber’s work aims to treat conditions like ALS, the U.S. Defense Department warns that China’s military is investigating this exact technology to engineer "super soldiers" with enhanced situational awareness. Analysts call Lieber "Exhibit A" for why U.S. safeguards are failing; despite being caught and punished, one of America’s greatest scientific minds simply took his expertise to the very regime the U.S. was trying to keep it from. As Lieber told a Shenzhen conference in December: "I arrived with a dream... my own goals are to make Shenzhen a world leader." #CharlesLieber #ChinaTech #BrainComputerInterface #NationalSecurity #Shenzhen #Harvard #AI #Neurotech









China's ambassador just told Canada which of its MPs are allowed to travel and which international waters its navy is allowed to sail through. And he delivered that message right after Canada handed Beijing a trade deal. In an interview published May 1, 2026, Chinese Ambassador Wang Di warned Ottawa that sending parliamentarians to Taiwan or transiting warships through the Taiwan Strait would damage the new "strategic partnership" signed by Prime Minister Carney in January. He called the Taiwan Strait transits "harassment and even provocation." He described any official contact by Canadian MPs with Taiwan's government as "hurtful." To be precise about what is actually being demanded here: China is telling a G7 democracy that its elected representatives cannot visit a democratic island, and that its navy cannot sail through an international waterway that the entire world recognizes as such. Not Chinese territorial waters. An international strait. Canada has transited that waterway 11 times under Trudeau and once under Carney. Every single transit was legal. Every single one prompted a protest from Beijing. Two Liberal MPs quietly cut short a Taiwan trip in January specifically to avoid complicating Carney's Beijing visit. The CCP's approach to partnerships is consistent and documented: offer economic incentives, extract political concessions, then expand the list of concessions. Canada signed a trade deal and received, in return, a formal list of things its parliament and military are no longer supposed to do. #Canada #CCP #China #Taiwan #TaiwanStrait #CanadianPolitics #Sovereignty #Geopolitics #FreedomOfNavigation




>America funds the world’s pharmaceutical innovation >Europe forces drug companies to slash prices >pharma raises prices on Americans to cover the losses Same medicine. Often 3x more expensive in the US than in Europe. Europe still refuses to pay fair prices, effectively making Americans subsidize their healthcare. Only U.S. companies are truly funding new drug development. Europe free-rides. Solution: Section 301. The USTR would investigate and respond to these unfair foreign practices hurting American patients and innovation.







